Enanta Pharmaceuticals Inc. (ENTA)
NASDAQ · Healthcare
Enanta Pharmaceuticals Inc. Long Term Debt 2020–2025
Enanta Pharmaceuticals Inc. annual long term debt history from 2020 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Enanta Pharmaceuticals Inc. long term debt as of September 30, 2025: 54.8M, a 1.51% increase year-over-year.
- Enanta Pharmaceuticals Inc. long term debt for 2025 were 54.8M, a 1.51% increase from 2024.
- Enanta Pharmaceuticals Inc. long term debt for 2024 were 53.9M, a 153.99% increase from 2023.
- Enanta Pharmaceuticals Inc. long term debt for 2023 were 21.2M, a 5.07% decrease from 2022.
- Enanta Pharmaceuticals Inc. long term debt for 2022 were 22.4M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Enanta Pharmaceuticals Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $55 |
| 2024 | $54 |
| 2023 | $21 |
| 2022 | $22 |
| 2021 | $1 |
| 2020 | $4 |
Enanta Pharmaceuticals Inc. Long Term Debt — FAQ
Enanta Pharmaceuticals Inc. (ENTA) long term debt over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ENTA's long term debt history?
The chart and table above show Enanta Pharmaceuticals Inc.'s long term debt by year and by quarter, including the growth rate.